Chimerix reported $0 in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Ardelyx USD 17.74M 111.62M Dec/2025
aTyr Pharma USD 2.86M 126.59K Sep/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Gilead Sciences USD 1.78B 40M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Merck USD 6.44B 157M Sep/2025
Novavax USD 11.54M 1.97M Dec/2025